Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors

(2018) Serigne N. Lo et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update

(2018) Sandra L. Wong et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

(2017) Jeffrey Weber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

(2017) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

(2017) Mark B. Faries et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma

(2017) Georgina V. Long et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of Sentinel Lymph Node Biopsy in Patients with Thin Melanoma

(2017) Robert H. I. Andtbacka et al.   Journal of the National Comprehensive Cancer Network

Critical Assessment of Clinical Prognostic Tools in Melanoma

(2016) Alyson L. Mahar et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis

(2016) Erin Cordeiro et al.   ANNALS OF SURGICAL ONCOLOGY

American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine

(2016) Michael W. Kattan et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

(2016) Ulrike Leiter et al.   LANCET ONCOLOGY

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

(2015) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

(2014) Georgina V. Long et al.   NEW ENGLAND JOURNAL OF MEDICINE

The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patients

(2013) Augustinus P.T. van der Ploeg et al.   EUROPEAN JOURNAL OF CANCER

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

(2013) Dale Han et al.   JOURNAL OF CLINICAL ONCOLOGY

Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia

(2012) Adèle C. Green et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma

(2011) Rajmohan Murali et al.   ANNALS OF SURGERY

Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes

(2009) Rajmohan Murali et al.   CANCER

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With Melanoma

(2008) Jeffrey E. Gershenwald et al.   JOURNAL OF CLINICAL ONCOLOGY